AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15278645 — intervention group
Group type: COMPARATOR
Intervention: Commercial 1.5% lidocaine with epinephrine (pH 5.72)
Number of subjects: 34
Study 6870483 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 0
Study 6870483 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentobarbital
Number of subjects: 0
Study 31361909 — intervention group
Group type: EXPERIMENTAL
Intervention: Trypsin plus collagenase
Number of subjects: 22
Study 31361909 — intervention group
Group type: EXPERIMENTAL
Intervention: Trypsin alone
Number of subjects: 22
Study 31361909 — intervention group
Group type: COMPARATOR
Intervention: Dermabrasion with vehicle alone
Number of subjects: 22
Study 30770525 — intervention group
Group type: EXPERIMENTAL
Intervention: Prototype Willingness Model (PWM) based interventions
Number of subjects: 315
Study 28593698 — intervention group
Group type: EXPERIMENTAL
Intervention: Receptive language
Number of subjects: 200
Study 28593698 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressive language
Number of subjects: 200
Study 26481726 — intervention group
Group type: EXPERIMENTAL
Intervention: Subthreshold HD stimulation (1200 Hz/200 μsec/amplitude 90% paresthesia threshold)
Number of subjects: 15
Study 26481726 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional stimulation (60 Hz/350 μsec)
Number of subjects: 15
Study 26481726 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 15
Study 26600007 — intervention group
Group type: EXPERIMENTAL
Intervention: 200mg of mifepristone per day
Number of subjects: 65
Study 26600007 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 65
Study 23905371 — intervention group
Group type: EXPERIMENTAL
Intervention: Bushen huoxue recipe (BHR)
Number of subjects: 265
Study 23905371 — intervention group
Group type: COMPARATOR
Intervention: Conjugated estrogens and medroxyprogesterone acetate
Number of subjects: 265
Study 23905371 — intervention group
Group type: EXPERIMENTAL
Intervention: BHR + conjugated estrogens and medroxyprogesterone acetate
Number of subjects: 265
Study 21459975 — intervention group
Group type: EXPERIMENTAL
Intervention: Group therapy intervention (manual based developmental group therapy programme)
Number of subjects: 366
Study 21459975 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 366
Study 19828574 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated patient (SP) visits with feedback
Number of subjects: 56
Study 19828574 — intervention group
Group type: COMPARATOR
Intervention: Pharmacy educators (PE) feedback
Number of subjects: 56
Study 16888872 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung-volume-reduction surgery (LVRS)
Number of subjects: 1218
Study 16888872 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung-volume-reduction surgery (LVRS) in upper-lobe patients with low exercise capacity
Number of subjects: 1218
Study 16888872 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung-volume-reduction surgery (LVRS) in upper-lobe-predominant and high-exercise-capacity patients
Number of subjects: 1218
Study 16888872 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 1218
Study 15639688 — intervention group
Group type: EXPERIMENTAL
Intervention: EZE/SIMVA (10/10, 10/20, 10/40, or 10/80 mg)
Number of subjects: 1528
Study 15639688 — intervention group
Group type: EXPERIMENTAL
Intervention: EZE/SIMVA
Number of subjects: 1528
Study 15639688 — intervention group
Group type: COMPARATOR
Intervention: SIMVA
Number of subjects: 1528
Study 11730077 — intervention group
Group type: EXPERIMENTAL
Intervention: Affective psychotic patients
Number of subjects: 707
Study 11730077 — intervention group
Group type: COMPARATOR
Intervention: Schizophrenic patients
Number of subjects: 707
Study 10667618 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (50 mg/day, increased to 100 mg/day if necessary)
Number of subjects: 197
Study 10667618 — intervention group
Group type: COMPARATOR
Intervention: Moclobemide (300 mg/day, increased to 450 mg/day if necessary)
Number of subjects: 197
Study 10667618 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 197
Study 10667618 — intervention group
Group type: COMPARATOR
Intervention: Moclobemide
Number of subjects: 197
Study 7701456 — intervention group
Group type: EXPERIMENTAL
Intervention: Autogenic drainage
Number of subjects: 18
Study 7701456 — intervention group
Group type: COMPARATOR
Intervention: Active cycle of breathing techniques (ACBT)
Number of subjects: 18
Study 7701456 — intervention group
Group type: COMPARATOR
Intervention: ACBT
Number of subjects: 18
Study 7701456 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 18
Study 2926343 — intervention group
Group type: EXPERIMENTAL
Intervention: American Lung Association's Because You Love Your Baby smoking intervention (ALA)
Number of subjects: 109
Study 2926343 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care protocol (non-ALA)
Number of subjects: 109
Study 343748 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraluminal fluorouracil (30 mg/kg) with intravenous fluorouracil (10 mg/kg) on the first two postoperative days and five subsequent courses of oral fluorouracil (90 mg/kg) over one year.
Number of subjects: 203
Study 343748 — intervention group
Group type: COMPARATOR
Intervention: Intraluminal control (saline)
Number of subjects: 203
Study 31264294 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose CBD co-administered with THC
Number of subjects: 0
Study 31264294 — intervention group
Group type: COMPARATOR
Intervention: Placebo (implied control)
Number of subjects: 0
Study 30450532 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (paclitaxel/carboplatin with or without bevacizumab)
Number of subjects: 43
Study 30450532 — intervention group
Group type: EXPERIMENTAL
Intervention: Leptin/adiponectin ratio (L/A) before treatment
Number of subjects: 43
Study 30450532 — intervention group
Group type: EXPERIMENTAL
Intervention: Adiponectin and leptin levels
Number of subjects: 43
Study 27809651 — intervention group
Group type: EXPERIMENTAL
Intervention: NiTiBOND® prosthesis (nitinol group)
Number of subjects: 50
Study 27809651 — intervention group
Group type: COMPARATOR
Intervention: Fully fluoroplastic piston (fluoroplastic group)
Number of subjects: 50
Study 27809651 — intervention group
Group type: COMPARATOR
Intervention: Fully titanium piston (first titanium group)
Number of subjects: 50
Study 27809651 — intervention group
Group type: COMPARATOR
Intervention: Fully titanium piston (last titanium group)
Number of subjects: 50
Study 25633893 — intervention group
Group type: EXPERIMENTAL
Intervention: Polynephron dialysis membrane
Number of subjects: 47
Study 25633893 — intervention group
Group type: COMPARATOR
Intervention: Helixone and polyamide (control)
Number of subjects: 47
Study 23807065 — intervention group
Group type: EXPERIMENTAL
Intervention: Female Veterans reporting sexual harassment
Number of subjects: 2344
Study 23807065 — intervention group
Group type: EXPERIMENTAL
Intervention: Female Veterans reporting combat exposure
Number of subjects: 2344
Study 23807065 — intervention group
Group type: COMPARATOR
Intervention: Probable PTSD symptoms in female and male Veterans
Number of subjects: 2344
Study 23807065 — intervention group
Group type: COMPARATOR
Intervention: Symptomatic anxiety in female and male Veterans
Number of subjects: 2344
Study 23807065 — intervention group
Group type: EXPERIMENTAL
Intervention: Probable depression in female Veterans
Number of subjects: 2344
Study 23807065 — intervention group
Group type: EXPERIMENTAL
Intervention: Problematic alcohol use in female Veterans
Number of subjects: 2344
Study 23807065 — intervention group
Group type: EXPERIMENTAL
Intervention: Harassment stress and PTSD in female Veterans
Number of subjects: 2344
Study 23807065 — intervention group
Group type: COMPARATOR
Intervention: Harassment stress and PTSD in male Veterans
Number of subjects: 2344
Study 23807065 — intervention group
Group type: EXPERIMENTAL
Intervention: Combat stress and PTSD in female Veterans
Number of subjects: 2344
Study 23807065 — intervention group
Group type: COMPARATOR
Intervention: Combat stress and PTSD in male Veterans
Number of subjects: 2344
Study 21688658 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal analgesia with paracetamol, lornoxicam, and epidural ropivacaine (Group 1)
Number of subjects: 30
Study 21688658 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal analgesia with paracetamol, epidural ropivacaine, and tramadol (Group 2)
Number of subjects: 30
Study 21688658 — intervention group
Group type: COMPARATOR
Intervention: Monoanalgesia with promedol (Comparison Group)
Number of subjects: 30
Study 19054793 — intervention group
Group type: EXPERIMENTAL
Intervention: Brachial artery flow‐mediated dilation (BAFMD) in healthy individuals (Group A)
Number of subjects: 80
Study 19054793 — intervention group
Group type: COMPARATOR
Intervention: Brachial artery flow‐mediated dilation (BAFMD) in pooled patients (Group B + C)
Number of subjects: 80
Study 19054793 — intervention group
Group type: COMPARATOR
Intervention: Comparison between groups B and C
Number of subjects: 80
Study 19054793 — intervention group
Group type: COMPARATOR
Intervention: Correlation of ankle‐brachial index/BAFMD
Number of subjects: 80
Study 16430565 — intervention group
Group type: EXPERIMENTAL
Intervention: Gel lubrication
Number of subjects: 55
Study 16430565 — intervention group
Group type: COMPARATOR
Intervention: No gel lubrication (control)
Number of subjects: 55
Study 15272096 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild or moderate to severe level of depressive symptoms at hospitalization
Number of subjects: 833
Study 15272096 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger age
Number of subjects: 833
Study 15272096 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 833
Study 15272096 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported previous diagnosis of a cardiac condition
Number of subjects: 833
Study 15272096 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported history of depression, anxiety, or stress
Number of subjects: 833
Study 11378806 — intervention group
Group type: EXPERIMENTAL
Intervention: High phenol diet (69 g per day of extra virgin olive oil rich in phenols)
Number of subjects: 46
Study 11378806 — intervention group
Group type: COMPARATOR
Intervention: Low phenol diet (69 g per day of extra virgin olive oil poor in phenols)
Number of subjects: 46
Study 9463202 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg of ketorolac
Number of subjects: 26
Study 9463202 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1 ml of 0.9% saline solution)
Number of subjects: 26
Study 10442378 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine and UFT plus oral calcium folinate
Number of subjects: 8
Study 2198315 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg pefloxacin (PEFLO) once daily
Number of subjects: 21
Study 2198315 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg ofloxacin (OFLO) once daily
Number of subjects: 21
Study 2198315 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy with WHO/MDT regimen
Number of subjects: 21
Study 412079 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetal retard
Number of subjects: 54
Study 412079 — intervention group
Group type: COMPARATOR
Intervention: Cinnarizine
Number of subjects: 54
Study 31396794 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT)
Number of subjects: 45
Study 31396794 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser acupuncture therapy (LAT)
Number of subjects: 45
Study 31396794 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sham laser)
Number of subjects: 45
Study 31567928 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic total mesorectal excision
Number of subjects: 71
Study 28614895 — intervention group
Group type: EXPERIMENTAL
Intervention: Endocuff-assisted colonoscopy
Number of subjects: 534
Study 28614895 — intervention group
Group type: COMPARATOR
Intervention: Standard colonoscopy
Number of subjects: 534
Study 26066346 — intervention group
Group type: EXPERIMENTAL
Intervention: Atazanavir (ATV) powder boosted with ritonavir (RTV) liquid plus optimized dual nucleoside reverse-transcriptase inhibitor (NRTI) background therapy
Number of subjects: 56
Study 23296830 — intervention group
Group type: COMPARATOR
Intervention: Limit-fed creep feed with no trace mineral supplementation (Nonsup)
Number of subjects: 34
Study 23296830 — intervention group
Group type: EXPERIMENTAL
Intervention: Limit-fed creep feed with trace mineral fortification (MIN+)
Number of subjects: 34
Study 23296830 — intervention group
Group type: EXPERIMENTAL
Intervention: Limit-fed creep feed without trace mineral fortification (MIN-)
Number of subjects: 34
Study 23296830 — intervention group
Group type: EXPERIMENTAL
Intervention: Limit-fed creep feed (LFC)
Number of subjects: 34
Study 21875474 — intervention group
Group type: EXPERIMENTAL
Intervention: Yanshu injection combined with IMRT and concomitant chemotherapy
Number of subjects: 60
Study 21875474 — intervention group
Group type: COMPARATOR
Intervention: Control group (IMRT and concurrent chemotherapy)
Number of subjects: 60
Study 19335225 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing gloves for 90 minutes or less
Number of subjects: 898
Study 19335225 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing gloves for 91-150 minutes
Number of subjects: 898
Study 19335225 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing gloves for more than 150 minutes
Number of subjects: 898
Study 19335225 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgeons
Number of subjects: 898
Study 19335225 — intervention group
Group type: EXPERIMENTAL
Intervention: First assistants
Number of subjects: 898
Study 19335225 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical nurses
Number of subjects: 898
Study 19335225 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of hand cream (cornstarch and ethanol)
Number of subjects: 898
Study 16449273 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Number of subjects: 0
Study 16449273 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic treatment
Number of subjects: 0
Study 16449273 — intervention group
Group type: COMPARATOR
Intervention: Cardiopulmonary disease
Number of subjects: 0
Study 16449273 — intervention group
Group type: COMPARATOR
Intervention: FEV1 <50% predicted
Number of subjects: 0
Study 16449273 — intervention group
Group type: COMPARATOR
Intervention: > or =4 AECBs in previous year
Number of subjects: 0
Study 16449273 — intervention group
Group type: COMPARATOR
Intervention: Use of acute bronchodilators
Number of subjects: 0
Study 16449273 — intervention group
Group type: COMPARATOR
Intervention: Age > or =65 years
Number of subjects: 0
Study 15038168 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucocorticosteroid administration
Number of subjects: 0
Study 11156667 — intervention group
Group type: EXPERIMENTAL
Intervention: His bundle ablation (HBA) and VVIR pacemaker
Number of subjects: 36
Study 11156667 — intervention group
Group type: COMPARATOR
Intervention: Atrioventricular modifying drugs and VVI pacemaker
Number of subjects: 36
Study 9414052 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous radiofrequency neurotomy
Number of subjects: 17
Study 9414052 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 7506182 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimesulide
Number of subjects: 71
Study 7506182 — intervention group
Group type: COMPARATOR
Intervention: Ketoprofen
Number of subjects: 71
Study 3538487 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (40 mg/day for 14 days)
Number of subjects: 33
Study 3538487 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 3538487 — intervention group
Group type: EXPERIMENTAL
Intervention: Serial PEF measurements
Number of subjects: 33
Study 3538487 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid response
Number of subjects: 33
Study 29262755 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct contact with mental illness
Number of subjects: 573
Study 29262755 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect contact with mental illness
Number of subjects: 573
Study 29262755 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenia
Number of subjects: 573
Study 29262755 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 573
Study 29262755 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholism
Number of subjects: 573
Study 29262755 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact experience (direct vs indirect)
Number of subjects: 573
Study 26796897 — intervention group
Group type: EXPERIMENTAL
Intervention: Active comparator mouthrinse
Number of subjects: 23
Study 26796897 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental 5% CSPS dentifrice
Number of subjects: 23
Study 26796897 — intervention group
Group type: EXPERIMENTAL
Intervention: Marketed 5% CSPS dentifrices
Number of subjects: 23
Study 26796897 — intervention group
Group type: COMPARATOR
Intervention: Negative control dentifrice
Number of subjects: 23
Study 24959794 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation breathing and progressive muscle relaxation (twice a day for 8 weeks)
Number of subjects: 152
Study 24959794 — intervention group
Group type: COMPARATOR
Intervention: Wait-list group (no intervention)
Number of subjects: 152
Study 22428471 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal fentanyl 25 microg plus hyperbaric bupivacaine 2.5 mg (Group BF)
Number of subjects: 99
Study 21090162 — intervention group
Group type: EXPERIMENTAL
Intervention: Open ear canal hearing aids with counselling and sound enrichment
Number of subjects: 100
Study 18523382 — intervention group
Group type: EXPERIMENTAL
Intervention: Mucosa adhesive paste (0.1% F)
Number of subjects: 14
Study 18523382 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouth rinsing solution (0.2% NaF)
Number of subjects: 14
Study 18523382 — intervention group
Group type: COMPARATOR
Intervention: Toothpaste (0.5% F)
Number of subjects: 14
Study 18523382 — intervention group
Group type: COMPARATOR
Intervention: Tablet (0.75 mg F)
Number of subjects: 14
Study 16419491 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine treatment (Group B)
Number of subjects: 108
Study 16419491 — intervention group
Group type: COMPARATOR
Intervention: Untreated subclinical hypothyroidism (Group C)
Number of subjects: 108
Study 16419491 — intervention group
Group type: COMPARATOR
Intervention: Normal TSH (Group A)
Number of subjects: 108
Study 16419491 — intervention group
Group type: EXPERIMENTAL
Intervention: Subclinical hypothyroidism (Group B and C)
Number of subjects: 108
Study 12585791 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Passive Motion (CPM) and Standardized Exercises (SEs)
Number of subjects: 120
Study 12585791 — intervention group
Group type: EXPERIMENTAL
Intervention: Slider-Board (SB) therapy and Standardized Exercises (SEs)
Number of subjects: 120
Study 12585791 — intervention group
Group type: COMPARATOR
Intervention: Standardized Exercises (SEs) alone
Number of subjects: 120
Study 12585791 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (CPM, SB therapy, SEs)
Number of subjects: 120
Study 10539832 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet glycoprotein IIb/IIIa inhibitor (eptifibatide)
Number of subjects: 82
Study 10539832 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 8762375 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet and exercise intervention programme
Number of subjects: 158
Study 1817618 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopentone 0.5 mg kg‐1
Number of subjects: 19
Study 1817618 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 0.25 mg kg‐1
Number of subjects: 19
Study 1817618 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 19
Study 7100824 — intervention group
Group type: EXPERIMENTAL
Intervention: Ornidazole (Tiberal) for 3 days
Number of subjects: 100
Study 7100824 — intervention group
Group type: COMPARATOR
Intervention: Doxycycline (Vibramycin) for 3 days
Number of subjects: 100
Study 30991137 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcuma longa (30 mg/kg/day)
Number of subjects: 0
Study 30991137 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28799861 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial therapy (IAT)
Number of subjects: 397
Study 28799861 — intervention group
Group type: COMPARATOR
Intervention: No intra-arterial therapy (COVES = 0)
Number of subjects: 397
Study 26851974 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine
Number of subjects: 7
Study 26851974 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 23721506 — intervention group
Group type: EXPERIMENTAL
Intervention: losartan
Number of subjects: 463
Study 22664976 — intervention group
Group type: EXPERIMENTAL
Intervention: IDX375 200 mg BID
Number of subjects: 43
Study 22664976 — intervention group
Group type: EXPERIMENTAL
Intervention: IDX375 (25-200 mg single ascending doses)
Number of subjects: 43
Study 22664976 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 43
Study 18718110 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary pain treatment allocation protocol
Number of subjects: 220
Study 18718110 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 220
Study 17578470 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium supplementation (128 mg slow‐release magnesium stearate)
Number of subjects: 4494
Study 17578470 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose sugar)
Number of subjects: 4494
Study 15377574 — intervention group
Group type: EXPERIMENTAL
Intervention: NHS Direct triage
Number of subjects: 4703
Study 15377574 — intervention group
Group type: COMPARATOR
Intervention: Practice based triage
Number of subjects: 4703
Study 11236051 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein hydrolysate formula
Number of subjects: 15
Study 11236051 — intervention group
Group type: COMPARATOR
Intervention: Standard preterm formula
Number of subjects: 15
Study 9929229 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized management of diabetes
Number of subjects: 15
Study 9929229 — intervention group
Group type: COMPARATOR
Intervention: Control group (no similar intervention)
Number of subjects: 15
Study 7721525 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant Incubator (INC)
Number of subjects: 62
Study 7721525 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated Water-Filled Mattress (HWM)
Number of subjects: 62